Hoya Invests in Medical Devices

Thursday, April 2 2015 | 00 h 00 min | Acquisitions

HOYA has announced an investment in Salutaris Medical Devices, Inc., a company specializing in medical devices for treatment of wet age-related macular degeneration (AMD).

Salutaris MD develops experimental hand-held instruments to treat AMD by precisely targeting lesions with radiation. Radiation therapy suppresses the growth of faulty blood vessels and reduces inflammation and scarring.

“The currently available treatment regimens for wet AMD are costly, burdensome and there is a large unmet need for more effective therapies. We are excited about our partnership with HOYA that will further enable our commercialization efforts,” said Dr. Laurence Marsteller, CEO of Salutaris MD.

The specific terms of the agreement were not disclosed.

Further Information: http://www.hoya.co.jp/english/company/news/20150326.html

EssilorLuxottica Expands Ophthalmology Footprint with Acquisition of Signifeye

EssilorLuxottica will acquire Signifeye, adding 15 Belgian clinics to its growing ophthalmology network and strengthening its integrated medical eye-care strategy.

Learn More

CORE Summarizes TFOS DEWS III Reports to Boost Dry Eye Knowledge

CORE has published issue 87 of Contact Lens Update, summarizing key findings from the TFOS DEWS III dry eye reports. Expert-authored content and downloadable PDFs provide clinicians with practical guidance on diagnosis, management, and evolving best practices.